2,3-Difluoro-5-(methoxycarbonyl)phenylboronic acid, 97%, 250mg

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 0.35 µm, 1 Piece(s)

TERT-BUTYL 3-THIA-6-AZABICYCLO[3.1.1]HEPTANE-6-CARBOXYLATE, 95.0%, 100mg

(4-FLUORO-2-HYDROXYPHENYL)-4-PIPERIDINYL-METHANONE, HCL (1:1), 95.0%, 250mg

(3-Cyano-4-methylphenyl)boronic acid, 95.0%, 1g

4-Bromoantipyrine>98.0%(HPLC)(T)5g

Ethyl 1-bromocyclobutanecarboxylate, 95.0%, 50g

(4-Amino-2-(ethylthio)pyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone, 98%, 50mg

N-Methyl-N-[4-(morpholin-4-ylsulfonyl)benzoyl]glycine, 95.0%, 250mg

CYCLOPROPANECARBOXYLIC ACID, 1-(4-METHYLPHENYL)-, METHYL ESTER, 95.0%, 500mg

(2-Bromoethoxy)-tert-butyldimethylsilane>96.0%(GC)5g

Sodium 4-isopropylbenzenesulfonate, 95%, 100g

1-(4-Methoxy-benzyl)-2-methyl-piperazine hydrochloride, 50mg